Please use this identifier to cite or link to this item: http://www.repositorio.uem.mz/handle258/694
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHlashwayo, Delfina F.-
dc.contributor.authorSigauque, Betuel-
dc.contributor.authorNoormahomed, Emılia V.-
dc.contributor.authorAfonso, Sonia M. S.-
dc.contributor.authorMandomando, Inacio M.-
dc.contributor.authorBila, Custodio G. Bila-
dc.date.accessioned2022-08-24T07:53:40Z-
dc.date.issued2021-01-27-
dc.identifier.citationHlashwayo DF, Sigau´que B, Noormahomed EV, Afonso SMS, Mandomando IM, Bila CG (2021) A systematic review and meta analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan Africa. PLoS ONE 16(1): e0245951.en_US
dc.identifier.issne0245951-
dc.identifier.urihttp://www.repositorio.uem.mz/handle258/694-
dc.description.sponsorshipThe manuscript writing and publication was supported by the Fogarty International Center of the National Institutes of Health (Office of the Director, National Institutes of Health), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and National Institute of Neurological Disorders and Strokeen_US
dc.language.isoengen_US
dc.publisherPLOS ONEen_US
dc.relation.ispartofseries16;1-
dc.rightsembargoedAcessen_US
dc.subjectAntibiotic resistanceen_US
dc.subjectGastroenteritisen_US
dc.subjectDiarrheaen_US
dc.subjectHIVen_US
dc.titleA systematic review and meta-analysis reveal that campylobacter spp. and antibiotic resistance are widespread in humans in subSaharan Africaen_US
dc.typearticleen_US
dc.description.embargo2024-01-10-
dc.description.resumoCampylobacter spp. are zoonotic bacteria that cause gastroenteritis in humans worldwide, whose main symptom is diarrhea. In certain cases, extra intestinal manifestations may occur, such as Guillain Barre´ syndrome. The bacteria cause severe diarrhea mostly in chil dren and in immunocompromised individuals. This review aims to address the prevalence of Campylobacter spp. in humans in sub-Saharan Africa. It also aims to understand the impact of HIV in the prevalence, as well as to report data on antibiotic resistance and propose research priorities. Methods We followed PRISMA guidelines to find studies on the occurrence of Campylobacter spp. in humans in all countries from sub-Saharan Africa. Studies published between 2000 and 2020 were searched in PubMed, Cochrane Library, CINAHL, African Index Medicus, African Journals Online, Google Scholar and Science Direct. We have conducted a random-effect meta-analysis and calculated the proportion of resistant isolates to different antibiotics. Results and discussion We found 77 studies that described such occurrence in humans in 20 out of 53 sub-Saharan African countries. Campylobacter jejuni was the most prevalent species. Pooled prevalence was 9.9% (CI: 8.4%–11.6%). No major variations within the different sub-regions were found. Most studies reported Campylobacter spp. as the cause of diarrhea, mainly in chil dren. Some studies reported the bacteria as a possible etiologic agent of acute faralysis and urinary tract infection. Campylobacter spp. presented a higher pooled preva lence in HIV infected patients, although not statistically significant. High proportions of resis tant strains were reported for many antibiotics, including erythromycin and tetracycline. Conclusion Campylobacter spp. occur in sub-Saharan Africa, although information is scarce or inexis tent for many countries. Research priorities should include investigation of the understudied species; extra intestinal manifestations; the impact of HIV infection and associated risk fac tors. Control strategies should be reinforced to contain the spread of this pathogen and drug resistance.en_US
dc.journalPLOS ONEen_US
Appears in Collections:Artigos Publicados em Revistas Cientificas - FAVET

Files in This Item:
File Description SizeFormat 
2020 -Fafetine, José Manuel.pdffeeee1.76 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.